As Director of Research for the Neuroendocrine Tumor Research Foundation (NETRF), Effie Tzameli, Ph.D. is responsible for developing and implementing NETRF’s research strategy and advancing the foundation’s research portfolio. As a representative of NETRF, Effie interacts with scientists in the field to promote the organization’s mission, foster collaborative relationships, and attract new researchers to the field.
“I am very excited to join NETRF and contribute to the mission of the Foundation”, says Dr. Tzameli. “I am committed to working towards finding and funding innovative and cutting-edge research to help decipher the molecular underpinnings of neuroendocrine tumors”.
Effie came to NETRF from Cell Press where she was Editor-in-Chief of the Reviews Journal “Trends in Endocrinology and Metabolism” for more than five years. Prior to that, Effie was Junior faculty at Beth Israel Deaconess Medical Center and Harvard Medical School. Effie has extensive research experience in metabolism and other related research areas, and strong technical expertise that ranges from test tube assays to the generation of animal models. Her research work has appeared in several high impact peer reviewed journals including Molecular and Cellular Biology (MCB), The Journal of Clinical Investigation (JCI), Cell Metabolism, Nature and Nature Medicine. She has also written several editorials.
“Effie brings a wealth of experience and a deep-seated commitment to mission to our team. We are thrilled to have such a talented and passionate Director to help us accelerate our research,” says Executive Director Ron Hollander.
Effie completed her post-doctoral studies at Massachusetts General Hospital, Harvard Medical School, and at Baylor College of Medicine. Effie has a Ph.D. in molecular biology from Boston University School of Medicine.